Presbyopia | ASCRS
Clinical Education

Presbyopia Resources

New in CME 24/7: A Taste of ASCRS 2023

Experience the best of ASCRS education

Join program co-chairs and faculty for an online CME 24/7 activity where you’ll gain pearls you can put into practice on day one. Captured at the 2023 ASCRS Summer Meeting, this program is designed to offer a "taste" of the best education ASCRS has to offer.

Earn up to 10 AMA PRA Category 1 Credits™ by participating in the nine sections in this online program.

Learn More

ASCRS Consensus Statement on Vuity

Leads: Douglas Rhee, MD, Cathleen McCabe, MD, Leon Herndon, MD, Rajesh Rao, MD

On August 16, 2022, the Prescribing Information for VUITY (pilocarpine hydrochloride ophthalmic solution) 1.25% was updated following a voluntary submission by Allergan, an AbbVie company, to the U.S. Food and Drug Administration (FDA). New information has now been included in the Warnings and Precautions, Postmarketing Experience, and Patient Counseling Information sections. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of VUITY.

Learn More

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.